Introduction
Hypertensive disorders are the most common medical complication of pregnancy with a reported incidence between 5 and 10 percent. The term hypertension in pregnancy is commonly used to describe a wide spectrum of patients who may have only mild elevations in blood pressure or severe hypertension with various organ dysfunctions (1) .Hypertensive disorders together with haemorrhage and infection form a deadly triad that contribute greatly to maternal morbidity and mortality. In India, it accounts for 24% of all maternal deaths. It is also a major cause of preterm birth, intrauterine growth restriction and perinatal mortality. The underlying pathophysiological mechanisms of gestational hypertension appear between 8-18 weeks of gestation.Homocysteine is atherogenic and thrombophilic. Elevated homocysteine levels are implicated in coronary, cerebro vascular and peripheral arterial disease, DVT and preeclampsia. It has been proved that homocysteine has a definite role in the setting of gestational hypertension (2, 3) .With this background this study aims at finding the relationship between plasma homocysteine and gestational hypertension.
II.
Aims And Objectives
2.1Aim:
This study is designed to find out the relationship between plasma homocysteine levels and occurrence of gestational hypertension.
2.2Objectives:
 To compare plasma homocysteine levels in both the groups.  To establish a relationship between plasma homocysteine and gestational hypertension.  To find out possible factors that might influence plasma homocysteine levels in hypertensive disorders of pregnancy.
III. Materials And Methods
Our study was a case control studyand enrolled 111 patients after obtaining informed consent, during the period January 2015 to December 2015 in Department of Obstetrics and Gynaecology, Coimbatore medical college hospital, Coimbatore. The cases of our study were postnatal patients who had gestational hypertension. The controls were postnatal patients who were comparable with the patients' groups with regard to social class, geographical area and age.
Gestational hypertension was defined as systolic BP> 140mm Hg & diastolic BP> 90mm Hg detected for the first time during pregnancy after 20 weeks of gestation. Preeclampsia was defined as gestational hypertension with proteinuria. Eclampsia defined as seizures that cannot be attributed to other causes in a women with preeclampsia. Proteinuria is defined as >1+ dipstick.Conventional sphygmomanometer was usedfor
IV. Results And Analysis
The mean age of the patients enrolled in the study was 23.59+3.6 years. The systolic blood pressure was in the range of 110-180 mm Hg and diastolic blood pressure 70-130mm Hg with an average of 133.6 +17.7/89+15.5 mmHg. Mean arterial pressure of 111 patients included in the study was in the range 83.33 and 176.67 with a mean value of 104.5+15.1mmHg. The average birth weight of the babies born to the patients included in the study was 2.8+0.4Kg. Finally, the plasma homocysteine levels measured in the patients were in the range of 6-54 with a mean value of 14.32+7.9 µmol/L.
In our study, majority of the patients were in the age group of <25 years (84), of which 42.8% were found to be hypertensive. On the other hand, 5 patients were more than 30 years old, out of which 80% were found to be hypertensive. However, in the present study, the p value of association of age with gestational hypertension was found to be 0.523 and hence it is statistically insignificant.
In our study, out of 111 patients, 59.5% patients were primipara. Out of the 61 patients, 52.5% were primipara and the remaining 47.5% were found to be multiparous. 16 patients had gestational hypertension, 68.6% were primi and the remaining 31.3% were multiparous. Out of 26 preeclampsia patients 61.5% were primipara and the remaining 38.5% were multiparous. Out of 8 eclampsia patients 87.5% were found to be primi and 12.5% were found to be multiparous. The p value of association between parity and gestational hypertension in our study is 0.230 and hence found to be insignificant.
Out of 61 normotensive patients, 54.1% had 1 live child, 45.9% had more than 1 live birth. Out of 16 Gestational hypertensive patients, 18.8% had no live child. 43.8% had atleast 1 live child. 37.4% had more than 1 live child. Out of 26 preeclampsia patients, 3.8% had no live child and 65.4% had 1 live child and the remaining 30.8% had more than 1 living child. The p value indicating the association between the number of live birth and gestational hypertension is <0.05% and hence there is a significant association between the two.
Out of 61 normotensive patients, 95.1% had no family history and the remaining 4.9% had family history of cardiovascular disease and gestational hypertension. In 16 gestational hypertension patients, 81.3% had no family history, 18.8% had a positive family history. Out of 26 preeclampsia patients, 57.7% had no family history, 42.3% had a family history. Out of 8 eclampsia patients, 62.5% had no family history and 37.5% had a significant family history. Hence, p value of this association is <0.001 which indicated a significant association between the family history of cardiovascular disease and gestational hypertension.
Out of 61 normotensive patients, only 6.6% had abnormal homocysteine levels. On the other hand, out of 16 gestational hypertensive patients 50% had abnormal homocysteine levels. Out of 26 preeclampsia patients 65.4% had abnormal homocysteine levels. Finally, out of 8 eclampsia patients 75% had abnormal homocysteine levels. The p value of this association is <0.001 and hence the association between the plasma homocysteine and gestational hypertension was found to be significant.
The correlation between various factors such as parity, family history of cardiovascular disease, systolic blood pressure, diastolic blood pressure, mean arterial pressure and plasma homocysteine levels were studied. It was found that there was no correlation between the parity and other factors. However, other factors excluding parity showed a positive correlation.
While analyzing the association between family history of cardiovascular disease and the abnormal plasma homocysteine levels, it was found that 20 patients out of the total 111 patients (18%) had positive history of cardiovascular disease. Out of those 20 patients, it was found that 10 patients (50%) had abnormal homocysteine levels. Hence, the Chi square value of family history of cardiovascular disease and plasma homocysteine levels is 3.854 and p<0.05 which was statistically significant.
V. Discussion
Our study was conducted in the Departmentof Obstetrics and Gynaecology, Coimbatore medical college hospital, Coimbatore, with the aim of finding a relationship between plasma homocysteine levels and gestational hypertension with 111 participants Mean MAP in normal mothers as 93.33 mm Hg, in mothers with gestational hypertension was 111.88 mmHg, in preeclampsia was 118.72 mmHg and in eclampsia was 128.25mmHg. The mean SBP, DBP and MAP were significantly higher in cases than in controls.
Study Of Relationship Between Plasma Homocysteine Levels And Gestationalhypertension
Mean plasma homocysteine in normal mothers was 10.50 mol/L, in mothers with gestational hypertension was 16.43 mol/L, in preeclampsia was 20.23 mol/L and in Eclampsia was 20.10 mol/L. Mean Plasma homocysteine levels were found to be significantly higher in cases compared to controls.Several studies (4, 5, 6 ) also published results which correlated with the results of the present study. Amir et al., 2006 (4) reported that the fasting plasma homocysteine levels were higher in patients with preeclampsia when compared to normotensive pregnant women.This observation has been highlighted by Mansour et al, 2011 (7), where serum homocysteine was found to be 3 folds higher in patients with severe preeclampsia There was a significant association between live births and gestational hypertension (p<0.05). The higher the numbers of live children lower the occurrences of gestational hypertension.There was significant association between family history of cardiovascular disease and gestational hypertension (p<0.001). There was a significant association between plasma homocysteine levels and gestational hypertension (p<0.001)
Ingec et al in 2005 (6) showed that homocysteine concentration in severe preeclamptic and eclamptic women were significantly higher than mild preeclamptic and normotensive women concluding that elevated plasma homocysteine levels in early pregnancy can increase the risk of developing severe preeclampsia which correlated with the results of the present study. Also, recent study has highlighted that the higher levels of homocysteine is associated with severity of hypertension and also associated maternal complications such as abruption, retinopathy, MODS, eclampsia and maternal mortality (9) El abd et al in 2009 (10) conducted a case control study which highlighted the positive correlation between plasma homocysteine levels and SBP, DBP and MAP and at the same time disproved its association with age. Vincent et al in 2009 (11), also established the positive correlation between the mean homocysteine levels and gestational hypertension, and the levels are proportional to the severity of hypertension.The results of the present study also correlated with the established results which suggested that MAP, SBP, DBP were higher in patients with elevated plasma homocysteine levels.
VI. Conclusion
To conclude, in our study it has been established that a positive relationship exists between plasma homocysteine levels and gestational hypertension. Also, it has been highlighted that the levels of plasma homocysteine are higher in patients with positive family history of cardiovascular disease, and higher homocysteine levels indicate severe disease.Increased levels of plasma homocysteine in pregnant women could be used as a potential marker for predicting gestational hypertension and its severity. 
